The obesity medicine specialist says weight on the scale is only part of the picture when someone is taking a GLP-1 medication.
Recap by typeshit. Post by Facebook on Facebook.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A search result from Polskie Radio on oral semaglutide and weight loss, with no details given beyond the question itself.
She says the cause is a calorie surplus: some patients still manage high calorie foods and aren't exercising enough while on the drugs.
A general rundown of how the two drugs work, who might benefit and what to know before starting, with no new findings or news.
Bloomberg reports people are trying unapproved, untested peptides hoping for sharper thinking and a competitive edge, fueling a fast-growing gray market.
Loading…